ZyVersa Therapeutics, Inc. financial statements
ZyVersa Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 24.95M | 10-K |
| Cash and equivalents | USD 101.78K | 10-Q |
ZyVersa Therapeutics, Inc. financials on 6ix · ZyVersa Therapeutics, Inc. on 6ix